Shelby L. Johnson
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 2
- Clinical Biochemistry top 10%
-
- Alzheimer's disease research and treatments 4
-
- Natural Antidiabetic Agents Studies 4
-
- Plant-Derived Bioactive Compounds 3
-
- Parkinson's Disease Mechanisms and Treatments 2
-
- Phytoestrogen effects and research 2
-
- Tannin, Tannase and Anticancer Activities 2
-
- Pluripotent Stem Cells Research 1
- Co-authors
- Navindra P. SeeramHang MaNicholas A. DaSilvaJoel A. DainWeixi LiuDhiraj VattemHyun Y. ParkMatthew J. Bertin
- Partner nations
- United StatesChinaAzerbaijan
In The Last Decade
Shelby L. Johnson
16 papers receiving 498 citations
Peers
Comparison fields: 5 of 89
- Biochemistry 120
- Biological Psychiatry 28
- Complementary and alternative medicine 64
- Aging 13
- Clinical Biochemistry 36
Countries citing papers authored by Shelby L. Johnson
This map shows the geographic impact of Shelby L. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelby L. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelby L. Johnson more than expected).
Fields of papers citing papers by Shelby L. Johnson
This network shows the impact of papers produced by Shelby L. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelby L. Johnson. The network helps show where Shelby L. Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shelby L. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2022 | 12 | |
| 3 | 2020 | 11 | |
| 4 | 2020 | 15 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 35 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 73 | |
| 9 | 2019 | 22 | |
| 10 | 2018 | 138 | |
| 11 | 2018 | 51 | |
| 12 | 2017 | 29 | |
| 13 | 2017 | 37 | |
| 14 | 2017 | 22 | |
| 15 | 2016 | 44 | |
| 16 | 1968 | 1 | |
| 17 | 1967 | 0 | |
| 18 | 1967 | 1 |
About Shelby L. Johnson
Shelby L. Johnson is a scholar working on Applied Microbiology and Biotechnology, Biochemistry and Neurology, having authored 18 papers that have together received 506 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Natural Antidiabetic Agents Studies (4 papers), Plant-Derived Bioactive Compounds (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Phytoestrogen effects and research (2 papers), Tannin, Tannase and Anticancer Activities (2 papers), Phytochemicals and Antioxidant Activities (2 papers) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Biochemistry (120 citations), Biological Psychiatry (28 citations) and Complementary and alternative medicine (64 citations). Shelby L. Johnson has collaborated with scholars based in United States, China and Azerbaijan. Frequent co-authors include Navindra P. Seeram, Hang Ma, Nicholas A. DaSilva, Joel A. Dain, Weixi Liu, Dhiraj Vattem, Hyun Y. Park, Matthew J. Bertin, Paula Grammas and Weixi Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.